Antiplatelet resistance in stroke - Wikidata - awgldk - TriplyDB

Antiplatelet resistance in stroke

Antiplatelet resistance in stroke

http://www.wikidata.org/entity/Q22305927

about

Circulating primers enhance platelet function and induce resistance to antiplatelet therapy.Comparison of a new P2Y12 receptor specific platelet aggregation test with other laboratory methods in stroke patients on clopidogrel monotherapy.Evaluating the Primary Prevention of Ischemic Stroke of Oral Antithrombotic Therapy in Head and Neck Cancer Patients with Radiation Therapy.Secondary prevention of stroke: Pleiotropic effects of optimal oral pharmacotherapy.Advancements in understanding the mechanisms of symptomatic lacunar ischemic stroke: translation of knowledge to prevention strategies.Blood Biomarkers in Minor Stroke and Transient Ischemic Attack.Adequate Platelet Function Inhibition Confirmed by Two Inductive Agents Predicts Lower Recurrence of Ischemic Stroke/Transient Ischemic Attack.Proteinuria Predicts Resistance to Antiplatelet Therapy in Ischemic Stroke.Glucose intolerance and insulin resistance as predictors of low platelet response to clopidogrel in patients with minor ischemic stroke or TIA.

P2860

Q36140286-2E5DC5C2-7B66-4C90-A9BF-BD76210C414C Q36976793-48465874-A6CA-4FD2-86D9-256D890CB806 Q37471378-439FA9C7-F503-4950-AD8D-99506251D7C2 Q38051636-C6DD6C68-90C6-4859-85F9-05A40CFCE585 Q38184638-0D6A99C5-FD6E-4623-BF21-1C5E7CE3EC3B Q38850520-D8E2D307-2678-4EF0-ABC8-B5C67F0FC8CD Q41620962-E18C26D7-FAA4-4B9C-AC94-BDF4C7CD726F Q47298846-EC61B215-F265-491E-8D6A-FDDB4A798A1D Q51342808-456493AD-9326-49F7-8325-3A69245BF5D2

P2860

Antiplatelet resistance in stroke

http://www.wikidata.org/entity/Q22305927

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Antiplatelet resistance in stroke

@ast

Antiplatelet resistance in stroke

@en

Antiplatelet resistance in stroke

@en-gb

Antiplatelet resistance in stroke

@nl

type

label

Antiplatelet resistance in stroke

@ast

Antiplatelet resistance in stroke

@en

Antiplatelet resistance in stroke

@en-gb

Antiplatelet resistance in stroke

@nl

prefLabel

Antiplatelet resistance in stroke

@ast

Antiplatelet resistance in stroke

@en

Antiplatelet resistance in stroke

@en-gb

Antiplatelet resistance in stroke

@nl

P1433

Q22305927-85229DC6-6587-40A4-8343-0D7053E2E7E3

P1476

Q22305927-887454F6-C67B-4FBD-A208-1985E171A563

P2093

Q22305927-98609A16-45C1-43BE-94B6-C9F775C75727

Q22305927-C2089B4B-C1EE-4614-A96A-30D49D8373A5

Q22305927-FF420A9A-73D7-40EC-8FA9-C6D2077F4415

P2860

Q22305927-0199B777-04DC-450E-8F26-1CC9D05FC6FB

Q22305927-01B548BB-723B-46D8-A3AD-A6865D126489

Q22305927-03505FB3-6D3D-45EE-AB1C-32AA8B235724

Q22305927-06BD38D2-B0A3-45C6-9944-757286EABFED

Q22305927-071AA5ED-3E87-4F86-AF58-92E544B68646

Q22305927-0884D434-81B8-4D74-A512-03A6223122BA

Q22305927-0A0B50E5-2FDD-45D4-AAA3-D4CBAA485C0C

Q22305927-0ADC9480-97A1-4D76-9F5F-3DBFEAD4B352

Q22305927-0F873260-CE37-4F6B-969A-ADAFCC84ECA3

Q22305927-1A6E2367-02E5-4851-9AD9-EE2193D3FD4E

P304

Q22305927-53F600C4-1290-4B42-BFBE-2466573F6E34

P31

Q22305927-B6223D4A-6099-49D5-9D01-FD9F6CFDFFE9

P356

Q22305927-07B49374-D8AE-4DF2-A2A8-EF1FC2BA7C3D

P407

Q22305927-5B026139-C286-4E58-A093-0800C9759886

P433

Q22305927-CBD073E1-5D21-4248-9386-A5FDE1A096D6

P478

Q22305927-3AD63FD8-5E2E-4782-84CE-1D11365AB024

P577

Q22305927-EB9F6193-739C-457E-8A1B-A9C5E6F2F838

P5875

Q22305927-8564BBBD-AF81-4329-A2F0-5E153B233BD7

P698

Q22305927-289F67A6-E6BF-4EFB-B23D-30EF6C0CA58E

P932

Q22305927-80720B14-8F64-4434-929D-55E0184FA09A

P356

P1433

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

P1476

Antiplatelet resistance in stroke

@en

P2093

Ethem Murat Arsava

http://www.w3.org/2001/XMLSchema#string

Hakan Ay

http://www.w3.org/2001/XMLSchema#string

Mehmet Akif Topçuoglu

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis

Antiplatelet effect of aspirin in patients with cerebrovascular disease

Screening for aspirin responsiveness after transient ischemic attack and stroke: comparison of 2 point-of-care platelet function tests with optical aggregometry

Aspirin resistance: position paper of the Working Group on Aspirin Resistance

Low-dose aspirin increases aspirin resistance in patients with coronary artery disease

Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA

The role of exercise on platelet aggregation in patients with stable coronary artery disease: exercise induces aspirin resistant platelet activation

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

P304

251-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERN.10.203

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49822056

http://www.w3.org/2001/XMLSchema#string

P698

21306212

http://www.w3.org/2001/XMLSchema#string

P932

3086673

http://www.w3.org/2001/XMLSchema#string